Search & Analyze

Pfizer Ltd.

3,697.10−63.30 (−1.68%)

BSE · 30 Oct, 4:01 PM

: ₹16,867.42 Cr
: 123.01
: 1,500
: ₹3,775.40 - ₹3,672.30
: ₹5,329.05 - ₹3,590.00

Pfizer Ltd. (PFIZER) share price closed at ₹3,697.10 on the BSE on Friday, October 30, 2026, down by 1.68% from its of ₹3,760.40. In that session PFIZER reached a of 3,775.40 and of 3,672.30. The for the session was 3,701.54. The stands at 4,139.06 and is at 4,586.85. Looking at , the stock ended the session in Downtrend.

Stock Overview

₹3,767.85

₹3,760.40

₹3,701.54

₹4,139.06

Price 10.68% below

₹4,586.85

Price 19.40% below

Key Fundamentals

: 16,867.42 Cr₹16.87 Thousand Crore
: 29.97
: 123.01
: —
: —
: 229.22 Cr₹229.22 Crore
: 2.03 %
Sector
Industry: Pharmaceuticals & Drugs
: 38.71
: 0.00

Industry Comparison

Ratio	Company	Sector
	123.01	44.77
	0.00	0.20
	—	4.61
	1.86	1.81
	2.03 %	0.11 %
Operating Margin	19.12 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,778.25	38.91	4,26,661.74	0.90	1,995.07	-36.16%	16,198.71	11.88%	19.11
DIVI'S LAB. DIVISLAB	9,715.00	88.17	2,57,902.73	0.31	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,635.15	83.01	1,76,306.21	0.82	534.00	-9.64%	4,979.00	50.79%	19.27
LAURUSLABS LAURUSLABS	2,392.00	96.46	1,29,242.68	0.08	436.19	124.27%	2,206.37	33.44%	18.20
ZYDUSLIFE ZYDUSLIFE	1,244.00	27.50	1,24,089.48	0.08	990.20	-34.90%	8,017.00	21.96%	21.39
DR.REDDY'S DRREDDY	1,350.20	40.25	1,12,698.53	0.59	913.20	-31.69%	8,697.80	-1.48%	13.75
CIPLA LTD. CIPLA	1,380.00	38.48	1,11,488.55	0.94	851.51	-37.08%	7,403.93	-2.44%	16.00
Pfizer Ltd. PFIZER	3,697.10	123.01	16,867.42	2.03					54.15

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2003-04 (Nov)	FY 2004-05 (Nov)	FY 2005-06 (Nov)	FY 2006-07 (Nov)	FY 2007-08 (Nov)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	695.77	729.00	796.72	798.57	790.92
Less: Excise Duty	48.84	54.16	60.40	61.99	54.09
	646.92	674.84	736.33	736.57	736.83
EXPENDITURE :
Increase/Decrease in Stock	25.50	-6.29	-7.63	5.74	-18.86
Raw Material Consumed	173.21	195.96	194.62	185.14	214.80
Power & Fuel Cost	8.02	7.96	7.50	7.94	7.17
Employee Cost	81.08	98.57	100.37	98.71	98.43
Other Manufacturing Expenses	66.70	80.87	85.45	85.84	92.14
General and Administration Expenses	53.85	45.04	45.81	48.30	49.05
Selling and Distribution Expenses	99.57	96.59	103.95	106.89	99.87
Miscellaneous Expenses	48.28	40.15	40.57	41.51	42.98
	556.21	558.84	570.64	580.08	585.58
Operating Profit (Excl OI)	90.71	115.99	165.68	156.49	151.25
	14.09	33.24	33.47	321.80	71.10
	104.80	149.23	199.16	478.29	222.34
Interest	0.81	0.16	0.07	0.02
PBDT	103.99	149.07	199.08	478.28	222.34
	10.26	13.85	13.07	9.58	11.12
Profit Before Taxation & Exceptional Items	93.73	135.23	186.01	468.69	211.22
Exceptional Income / Expenses	-19.22	-23.37	-23.37	-17.35	207.91
	74.51	111.86	162.65	451.34	419.13
Provision for Tax	29.92	41.13	56.31	111.34	119.56
	44.59	70.73	106.33	340.00	299.57
Consolidated Net Profit	44.59	70.73	106.33	340.00	299.57
Profit Balance B/F	186.38	192.62	222.20	240.97	450.96
Appropriations	230.97	263.36	328.53	580.97	750.53
Equity Dividend %	100.00%	100.00%	125.00%	275.00%	125.00%
	15.48	23.70	35.63	113.94	100.39
Adjusted EPS	15.48	23.70	35.63	113.94	100.39

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2003-04 (Nov)	FY 2004-05 (Nov)	FY 2005-06 (Nov)	FY 2006-07 (Nov)	FY 2007-08 (Nov)
	28.80	29.84	29.84	29.84	29.84
Share Warrants & Outstandings	1.04
Total Reserves	309.69	346.11	409.91	619.88	871.25
Reserve excluding Revaluation Reserve	309.69	346.11	409.91	619.88	871.25
Revaluation reserve	0.00	0.00	0.00	0.00	0.00
	339.53	375.95	439.76	649.72	901.09
Unsecured Loans	12.00
Deferred Tax Assets / Liabilities	-6.35	-9.03	-14.36	-12.98	-22.67
Total Non-Current Liabilities	5.65	-9.03	-14.36	-12.98	-22.67
Trade Payables	100.78	120.16	137.62	92.43	108.18
Other Current Liabilities	16.45	16.26	8.14	14.17	14.50
Short Term Provisions	53.41	487.53	550.57	714.05	803.68
Total Current Liabilities	170.64	623.95	696.33	820.65	926.36
Total Liabilities	515.82	990.87	1,121.72	1,457.39	1,804.78
Gross Block	158.77	170.15	168.14	141.61	139.90
Less: Accumulated Depreciation	87.06	94.59	98.19	81.45	89.14
	71.71	75.56	69.96	60.16	50.76
	3.94	2.14	1.60	10.24	32.30
Non Current Investments	0.00	0.00	0.00	0.50	0.50
Long Term Investment	0.00	0.00	0.00	0.50	0.50
Total Non-Current Assets	75.65	77.71	71.56	70.91	83.56
Currents Investments	0.00	0.00	0.00	0.00	0.00
Inventories	75.01	90.71	99.31	95.85	124.99
Sundry Debtors	72.43	83.54	70.10	61.69	60.31
Cash and Bank	161.39	210.15	306.94	479.91	543.65
Other Current Assets	1.37	2.14	4.23	8.17	14.49
Short Term Loans and Advances	69.91	489.92	556.25	737.93	977.77
Total Current Assets	380.10	876.46	1,036.82	1,383.55	1,721.22
Net Current Assets (Including Current Investments)	209.46	252.52	340.50	562.90	794.86
Miscellaneous Expenses not written off	60.07	36.70	13.34	2.93
Total Assets	515.82	990.87	1,121.72	1,457.39	1,804.78
	26.66	24.59	49.87	62.54	27.99
Total Debt	12.00	0.00	0.00	0.00	0.00
	96.68	113.68	142.90	216.74	301.96
Adjusted Book Value	96.68	113.68	142.90	216.74	301.96

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2003-04 (Nov)	FY 2004-05 (Nov)	FY 2005-06 (Nov)	FY 2006-07 (Nov)	FY 2007-08 (Nov)
No of Months	12.00	12.00	12.00	12.00	12.00
	93.73	135.23	186.01	468.69	211.22
Adjustment	9.27	7.24	-8.73	-298.40	-49.50
Changes In working Capital	7.98	-2.41	11.64	-33.39	-7.89
Cash Flow after changes in Working Capital	110.98	140.06	188.92	136.91	153.83
Cash Flow from Operating Activities	87.21	102.74	123.19	16.63	237.76
Cash Flow from Investing Activities	-68.50	-73.08	-47.99	232.35	-78.87
Cash Flow from Financing Activitie	-14.71	-46.02	-33.82	-75.90	-95.20
Net Cash Inflow / Outflow	4.00	-16.36	41.38	173.09	63.69
Opening Cash & Cash Equivalents	21.89	26.36	10.00	306.83	479.91
Cash & Cash Equivalent on Amalgamation / Take over / Merger	0.48
Closing Cash & Cash Equivalent	26.36	10.00	51.38	479.91	543.61

Ratios

Valuation

123.01

71.21

21.84

29.97

Profitability

38.71

54.15

18.37

19.12

37.88

Leverage & Liquidity

0.00

1.86

Returns

2.03

0.48

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	63.92	63.92	63.92	63.92	63.92	63.92	63.92	63.92	63.92	63.92
	19.06	19.57	19.54	19.28	19.62	19.70	19.76	19.70	19.45	19.15
	17.02	16.50	16.54	16.80	16.45	16.37	16.32	16.37	16.63	16.93
	36.08	36.08	36.08	36.08	36.08	36.08	36.08	36.08	36.08	36.08
No. of Shareholders	1,06,098	98,824	1,05,015	1,08,261	1,03,222	1,03,480	1,00,933	99,545	1,02,478	1,04,472

Mutual Funds Invested(39)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 36 active funds hold 12.84% in Pfizer Ltd., contributing to ₹2.28K Cr of holdings

Fund				As of
QU Quant Small Cap Fund - Growth - Direct PlanSmall cap Fund	630.00	1.77	16,25,687	Sep '26
NI Nippon India Small Cap Fund - Growth - Direct PlanSmall cap Fund	467.40	0.58	12,06,103	Sep '26
IP ICICI Prudential Healthcare Fund - Growth - Direct PlanPharma & Health Care	166.32	2.42	4,29,173	Sep '26
IP ICICI Prudential Small Cap Fund - Growth - Direct PlanSmall cap Fund	138.34	1.41	3,56,978	Sep '26
NI Nippon India Multi Cap Fund - Growth - Direct PlanMulti Cap Fund	138.15	0.26	3,56,479	Sep '26
NI Nippon India Pharma Fund - Growth - Direct PlanPharma & Health Care	123.33	1.35	3,18,249	Sep '26
DS DSP Healthcare Fund - Growth - Direct PlanPharma & Health Care	102.16	2.72	2,63,627	Sep '26
DS DSP Large & Mid Cap Fund - Growth - Direct PlanLarge & Mid Cap	68.93	0.40	1,77,874	Sep '26
IP ICICI Prudential Value Fund - Growth - Direct PlanEquity - Value Fund	65.51	0.11	1,69,044	Sep '26
AB Aditya Birla Sun Life MNC Fund - Growth - Direct PlanMNC	59.55	1.97	1,53,670	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-26	Board Meeting	Quarterly Results
2026-07-20	Board Meeting	Quarterly Results
2026-07-07	AGM

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Pfizer Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

8 members across the board and senior leadership

Prajeet Nair

Director- Corporate Services & Company Secretary, Compliance Officer

—

Pradip Shah

Chairman

₹25.10 L

Mar '26

Meenakshi Nevatia

Managing Director

₹6.83 Cr

Mar '26

L Krishnakumar

Non Executive Independent Director

₹25.10 L

Mar '26

Amit Agarwal

Whole Time Director - Finance & Chief Financial Officer

₹2.75 Cr

Mar '26

Meena Ganesh

Non Executive Independent Director

₹26.10 L

Mar '26

P Rengan

Whole Time Director - Plant Operations

₹1.42 Cr

Mar '26

Sonia Singh

Non Executive Independent Director

₹23.65 L

Mar '26

PFIZER Latest News

News

3 of 3 articles

EQUITY7 Sept 2026 · 14:15

Pfizer informs about board meeting proceedings

EQUITY7 Sept 2026 · 14:09

Pfizer informs about board meeting proceedings

EQUITY12 May 2026 · 19:42

Pfizer reports Profit after tax of Rs 1998.20 Mln, in the March 2026 quarter

Pfizer Ltd.

Stock Overview

Price chart

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Valuation

Profitability

Leverage & Liquidity

Returns

Shareholding Pattern

Mutual Funds Invested(39)

Corporate Actions

Insider Trading

Sector Overview

Company Profile

Key Management

PFIZER Latest News

News